Afamelanotide
Scenesse, Melanotan I, Melanotan-1, MT-1, CUV1647, NDP-MSH
A synthetic alpha-MSH analogue approved as an implant for one rare light disease in adults. Melanotan I was a code name; products sold as it are not the drug.
What is documented about adverse effects, contamination and the legal status of peptides across the major regulatory jurisdictions.
Most compounds covered on this site are not approved medicines anywhere, which means no regulator has assessed them as safe or effective for any use in people. That is a specific, documented fact about each one, and it belongs alongside the efficacy research rather than in a disclaimer nobody reads.
This hub covers adverse event reports, product quality and contamination findings, and regulatory status by jurisdiction.
Scenesse, Melanotan I, Melanotan-1, MT-1, CUV1647, NDP-MSH
A synthetic alpha-MSH analogue approved as an implant for one rare light disease in adults. Melanotan I was a code name; products sold as it are not the drug.
CJC-1295 DAC, DAC:GRF
A synthetic analogue of growth hormone-releasing hormone. Two molecules share the name; only one was studied in people, for hormone levels.
PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, Hexanoyl-Tyr-Ile-Ahx-NH2, ATH-1001
A synthetic angiotensin IV analogue with no human study found. Its mechanism paper was retracted in 2025; FDA lists it as a withdrawn compounding nomination.
delta sleep-inducing peptide, delta sleep inducing peptide, delta-sleep-inducing peptide, emideltide, emideltide acetate, DSIP peptide, WAGGDASGE, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
A nine-amino-acid peptide named for an EEG effect in rabbits. Small 1980s human sleep studies were mixed, and independent ones found little or no benefit.
SS-31, SS31, MTP-131, Bendavia, Forzinity, RX-31, Ocuvia
A synthetic mitochondrial tetrapeptide given FDA accelerated approval in 2025 for Barth syndrome only. No trial has tested it against ageing.
Epithalon, Epithalone, AEDG, Ala-Glu-Asp-Gly, AEDG peptide
A four-amino-acid peptide studied almost only by one Russian network. No trial with a clinical outcome was found; its lifespan data are from animals.
copper tripeptide-1, GHK copper, prezatide copper, glycyl-L-histidyl-L-lysine copper
A three-amino-acid peptide bound to copper, used in skin care. Its human studies are topical; none injected GHK-Cu on its own or tested it systemically.
NNC 26-0161, Ipamorelin acetate
A synthetic growth hormone secretagogue. Never approved; its one published clinical trial, in postoperative ileus, did not show a benefit.
Melanotan 2, Melanotan-II, MT-II, MTII, MT2
A synthetic cyclic peptide sold for tanning. Its human trials total 23 men between 1996 and 2000, and none of the regulators checked has approved it.
MOTs-c, MOTs-C, MOTSc, MOTS-C, Mitochondrial-derived peptide MOTS-c, Mitochondrial open reading frame of the 12S rRNA-c
A 16-amino-acid peptide encoded in mitochondrial DNA. Its metabolic and lifespan data come from mice; no human trial of it has reported results.
TKPRPGP, Thr-Lys-Pro-Arg-Pro-Gly-Pro, TP-7, Selank acetate
A seven-amino-acid tuftsin analogue. Its patient studies are small, Russian and without placebo; FDA lists it as a withdrawn compounding nomination.
Semaks, ACTH(4-7)-Pro-Gly-Pro, ACTH(4-7)PGP, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro
A seven-amino-acid ACTH fragment analogue that FDA reports is registered in Russia. Its human studies are small, mostly Russian, and not placebo-randomised.
Safety
No regulator document found approves selank. What FDA, Health Canada and New Zealand's Medsafe have said about selling, importing and holding it.
Methodology
Cells, rats or people? Controls, sample size, lab markers, spin, sponsors, retractions and unposted trials, with real peptide examples.
Explainer
Peptides are short chains of amino acids. Some are hormones, dozens are approved drugs worldwide, and many sold as research peptides have no FDA approval.
Explainer
Research peptide is a sales label, not an FDA drug category. What research use only means in law, and what lab tests have found inside such vials.
Explainer
No FDA document found calls any peptide banned. What FDA does, and what the October 2026 HHS policy on six compounded peptides does and does not change.
Evidence review
No independent controlled study found shows DSIP or epitalon improving sleep measured in a sleep lab. FDA's 2026 briefings found no evidence of effectiveness.
Comparison
Semax and Selank compared on what was measured: small Russian studies, no head-to-head clinical trial, one shared fMRI study and different FDA histories.
Evidence review
Elamipretide, epitalon and MOTS-c: no human trial of any of them against ageing was found, and their lifespan data come from mice, rats and flies.
Safety
No regulator checked has approved Melanotan II. What authorities in the US, UK, Australia, Ireland, Denmark, Canada and Norway say about selling it.
Comparison
GHK-Cu on skin has a small, old, mostly null human record. No human study of it alone by injection was found. What each route rests on.
Safety
One is an approved medicine for a single use, two are not approved anywhere checked. What FDA, EMA and the TGA have published about each.
Safety
No. FDA has not approved retatrutide and says it cannot be compounded. What regulators found in products sold under its name, and what is unknown.
Safety
BPC-157 is not an approved medicine anywhere, is prohibited in sport at all times, and is widely sold. What regulators have actually published, and when.